EGLN3 Produkte
(Egl-9 Family Hypoxia Inducible Factor 3 (EGLN3))
Kategorien
Cellular oxygen sensor that catalyzes, under normoxic conditions, the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. Hydroxylates a specific proline found in each of the oxygen-dependent degradation (ODD) domains (N-terminal, NODD, and C-terminal, CODD) of HIF1A. Also hydroxylates HIF2A. Has a preference for the CODD site for both HIF1A and HIF2A. Hydroxylation on the NODD site by EGLN3 appears to require prior hydroxylation on the CODD site. Hydroxylated HIFs are then targeted for proteasomal degradation via the von Hippel-Lindau ubiquitination complex. Under hypoxic conditions, the hydroxylation reaction is attenuated allowing HIFs to escape degradation resulting in their translocation to the nucleus, heterodimerization with HIF1B, and increased expression of hypoxy-inducible genes. ELGN3 is the most important isozyme in limiting physiological activation of HIFs (particularly HIF2A) in hypoxia. Also hydroxylates PKM2 in hypoxia, limiting glycolysis. Under normoxia, hydroxylates and regulates the stability of ADRB2. Regulator of cardiomyocyte and neuronal apoptosis. In cardiomyocytes, inhibits the anti-apoptotic effect of BCL2 by disrupting the BAX-BCL2 complex. In neurones, has a NGF-induced proapoptotic effect, probably through regulating CASP3 activity. Also essential for hypoxic regulation of neutrophilic inflammation.
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte EGLN3 Kategorien
EGLN3 Antikörper
High quality antibodies with extensive validation data.
EGLN3 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene EGLN3 Antikörper
Produkt
Reaktivität
Applikation
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Applikation
WB, IHC, IF
Validierungen
- (6)
Kat. Nr.
ABIN6139990
Menge
100 μL
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
WB, IF
Validierungen
- (3)
Kat. Nr.
ABIN530188
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Human
Applikation
ELISA, IHC
Validierungen
- (2)
Kat. Nr.
ABIN7151448
Menge
100 μL
Datenblatt
Datenblatt
Empfohlene EGLN3 Proteine
Produkt
Reaktivität
Source
Validierungen
Kat. Nr.
Menge
Datenblatt
Reaktivität
Human
Source
Escherichia coli (E. coli)
Validierungen
- (1)
Kat. Nr.
ABIN7122748
Menge
50 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1352449
Menge
10 μg
Datenblatt
Datenblatt
Reaktivität
Human
Source
Wheat germ
Validierungen
- (1)
Kat. Nr.
ABIN1352451
Menge
10 μg
Datenblatt
Datenblatt
Neueste Publikationen zu unseren EGLN3 Produkten
: "RNA binding protein HuR regulates extracellular matrix gene expression and pH homeostasis independent of controlling HIF-1α signaling in nucleus pulposus cells." in: Matrix biology : journal of the International Society for Matrix Biology, Vol. 77, pp. 23-40, (2019) (PubMed).: "Hypoxia-inducible factor (HIF)-prolyl hydroxylase 3 (PHD3) maintains high HIF2A mRNA levels in clear cell renal cell carcinoma." in: The Journal of biological chemistry, Vol. 294, Issue 10, pp. 3760-3771, (2019) (PubMed).
: "Prolyl hydroxylase 3 stabilizes the p53 tumor suppressor by inhibiting the p53-MDM2 interaction in a hydroxylase-independent manner." in: The Journal of biological chemistry, Vol. 294, Issue 25, pp. 9949-9958, (2019) (PubMed).
: "Regulation of Hypoxia-Inducible Factor 1α during Hypoxia by DAP5-Induced Translation of PHD2." in: Molecular and cellular biology, Vol. 38, Issue 11, (2018) (PubMed).
: "The Factor Inhibiting HIF Asparaginyl Hydroxylase Regulates Oxidative Metabolism and Accelerates Metabolic Adaptation to Hypoxia." in: Cell metabolism, Vol. 27, Issue 4, pp. 898-913.e7, (2018) (PubMed).
: "PHD3 Acts as Tumor Suppressor in Mouse Osteosarcoma and Influences Tumor Vascularization via PDGF-C Signaling." in: Cancers, Vol. 10, Issue 12, (2018) (PubMed).
: "Intermittent hypoxia induces beneficial cardiovascular remodeling in left ventricular function of type 1 diabetic rat." in: Anatolian journal of cardiology, Vol. 19, Issue 4, pp. 259-266, (2018) (PubMed).
: "Defective Mitochondrial Cardiolipin Remodeling Dampens HIF-1α Expression in Hypoxia." in: Cell reports, Vol. 25, Issue 3, pp. 561-570.e6, (2018) (PubMed).
: "PHD3 regulates glucose metabolism by suppressing stress-induced signalling and optimising gluconeogenesis and insulin signalling in hepatocytes." in: Scientific reports, Vol. 8, Issue 1, pp. 14290, (2018) (PubMed).
: "Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization." in: Journal of experimental & clinical cancer research : CR, Vol. 36, Issue 1, pp. 32, (2017) (PubMed).
Synonyme und alternative Namen zu EGLN3
egl-9 family hypoxia-inducible factor 3 (egln3), egl-9 family hypoxia inducible factor 3 (EGLN3), egl-9 family hypoxia-inducible factor 3 L homeolog (egln3.L), egl-9 family hypoxia-inducible factor 3 (Egln3), 2610021G09Rik, AI505553, AI648162, EGLN3, Hif-p4h-3, HIFP4H3, HIFPH3, PHD-3, phd3, PHD3, Phd3, SM-20, wu:fj78a08, zgc:77019Bezeichner auf Proteinebene für EGLN3
- Hif-p4h-3
- egl nine homolog 3
- phd3
- egl nine homolog 3 (C. elegans)
- HIF-PH3
- HIF-prolyl hydroxylase 3
- HPH-3
- egl nine homolog 3, mitochondrial
- factor-responsive smooth muscle protein
- hypoxia-inducible factor prolyl hydroxylase 3
- prolyl hydroxylase domain-containing protein 3
- HIF prolyl hydroxylase 3
- HPH-1
- egl nine-like protein 3 isoform
Sie sind hier:
